000 01620 a2200481 4500
005 20250518032229.0
264 0 _c20190618
008 201906s 0 0 eng d
022 _a1527-3792
024 7 _a10.1097/JU.0000000000000170
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGaffney, Christopher
245 0 0 _aThe Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer.
_h[electronic resource]
260 _bThe Journal of urology
_c07 2019
300 _a96-101 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAged
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aBiopsy, Large-Core Needle
650 0 4 _aClinical Decision-Making
_xmethods
650 0 4 _aGene Expression Profiling
_xmethods
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aPatient Selection
650 0 4 _aProstate
_xpathology
650 0 4 _aProstatic Neoplasms
_xdiagnosis
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Assessment
_xmethods
650 0 4 _aRisk Factors
700 1 _aGolan, Ron
700 1 _aCantu, Miguel D
700 1 _aScognamiglio, Theresa
700 1 _aMcCarthy, Hiral
700 1 _aMosquera, Juan Miguel
700 1 _aMcClure, Timothy D
700 1 _aBarbieri, Christopher E
700 1 _aRobinson, Brian D
700 1 _aKhani, Francesca
773 0 _tThe Journal of urology
_gvol. 202
_gno. 1
_gp. 96-101
856 4 0 _uhttps://doi.org/10.1097/JU.0000000000000170
_zAvailable from publisher's website
999 _c29538363
_d29538363